annual CFF:
$264.87M+$282.95M(+1564.88%)Summary
- As of today (September 17, 2025), RDY annual cash flow from financing activities is $264.87 million, with the most recent change of +$282.95 million (+1564.88%) on March 31, 2025.
- During the last 3 years, RDY annual CFF has risen by +$279.33 million (+1932.45%).
- RDY annual CFF is now -57.38% below its all-time high of $621.50 million, reached on March 31, 2006.
Performance
RDY Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$701.00K(NaN%)Summary
- As of today (September 17, 2025), RDY quarterly cash flow from financing activities is -$701.00 thousand
- Over the past year, RDY quarterly CFF has dropped by -$123.99 million (-100.57%).
- RDY quarterly CFF is now -100.12% below its all-time high of $608.03 million, reached on March 31, 2006.
Performance
RDY quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$119.13M(NaN%)Summary
- As of today (September 17, 2025), RDY TTM cash flow from financing activities is $119.13 million
- Over the past year, RDY TTM CFF has increased by +$2.82 million (+2.43%).
- RDY TTM CFF is now -83.38% below its all-time high of $716.91 million, reached on December 31, 2006.
Performance
RDY TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RDY Cash from financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +1564.9% | -100.6% | +2.4% |
3 y3 years | +1932.5% | +99.5% | +165.2% |
5 y5 years | +179.8% | -100.7% | +178.9% |
RDY Cash from financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +185.1% | -100.6% | +99.5% | -62.3% | +138.4% |
5 y | 5-year | at high | +179.8% | -100.6% | +99.5% | -62.3% | +138.4% |
alltime | all time | -57.4% | +179.8% | -100.1% | +99.7% | -83.4% | +124.1% |
RDY Cash from financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$701.00K(-100.6%) | $119.13M(-62.3%) |
Mar 2025 | $264.87M(-1564.9%) | - | - |
Sep 2024 | - | $119.83M(-2.8%) | $315.57M(+171.3%) |
Jun 2024 | - | $123.29M(+7142.3%) | $116.30M(-743.0%) |
Mar 2024 | -$18.08M(-94.2%) | $1.70M(-97.6%) | -$18.09M(-72.6%) |
Dec 2023 | - | $70.75M(-189.1%) | -$66.12M(-43.9%) |
Sep 2023 | - | -$79.45M(+616.0%) | -$117.77M(-37.6%) |
Jun 2023 | - | -$11.10M(-76.1%) | -$188.78M(-39.2%) |
Mar 2023 | -$311.18M(+2052.8%) | -$46.33M(-342.5%) | -$310.56M(+62.3%) |
Dec 2022 | - | $19.11M(-112.7%) | -$191.38M(-20.0%) |
Sep 2022 | - | -$150.46M(+13.2%) | -$239.22M(+31.0%) |
Jun 2022 | - | -$132.87M(-282.4%) | -$182.64M(+1161.7%) |
Mar 2022 | -$14.45M(-204.9%) | $72.85M(-353.6%) | -$14.48M(-143.6%) |
Dec 2021 | - | -$28.73M(-69.4%) | $33.23M(-198.5%) |
Sep 2021 | - | -$93.89M(-366.0%) | -$33.73M(-31.5%) |
Jun 2021 | - | $35.29M(-70.7%) | -$49.22M(-454.9%) |
Mar 2021 | $13.78M(-104.1%) | $120.56M(-226.0%) | $13.87M(-158.9%) |
Dec 2020 | - | -$95.70M(-12.5%) | -$23.56M(-84.6%) |
Sep 2020 | - | -$109.38M(-211.2%) | -$152.69M(+1.1%) |
Jun 2020 | - | $98.38M(+18.3%) | -$150.98M(-54.8%) |
Mar 2020 | -$332.14M(+17.8%) | $83.13M(-137.0%) | -$334.05M(-32.3%) |
Dec 2019 | - | -$224.83M(+108.8%) | -$493.62M(+20.4%) |
Sep 2019 | - | -$107.67M(+27.1%) | -$410.06M(+5.2%) |
Jun 2019 | - | -$84.69M(+10.8%) | -$389.80M(+38.3%) |
Mar 2019 | -$281.93M(+486.3%) | -$76.44M(-45.9%) | -$281.85M(-4.1%) |
Dec 2018 | - | -$141.27M(+61.6%) | -$293.76M(+160.9%) |
Sep 2018 | - | -$87.41M(-475.8%) | -$112.61M(+346.8%) |
Jun 2018 | - | $23.26M(-126.3%) | -$25.20M(-48.0%) |
Mar 2018 | -$48.09M(+20.3%) | -$88.35M(-321.5%) | -$48.46M(-22.7%) |
Dec 2017 | - | $39.89M(-138.9%) | -$62.73M(+58.0%) |
Mar 2017 | -$39.97M(-83.7%) | -$102.61M(+98.2%) | -$39.70M(-191.7%) |
Dec 2016 | - | -$51.77M(-117.5%) | $43.28M(-10.9%) |
Sep 2016 | - | $296.46M(-263.1%) | $48.57M(-112.4%) |
Jun 2016 | - | -$181.79M(+825.7%) | -$391.71M(+50.7%) |
Mar 2016 | -$245.67M(+396.1%) | -$19.64M(-57.7%) | -$259.89M(+48.8%) |
Dec 2015 | - | -$46.47M(-67.7%) | -$174.67M(+78.2%) |
Sep 2015 | - | -$143.82M(+187.9%) | -$98.01M(+60.2%) |
Jun 2015 | - | -$49.96M(-176.2%) | -$61.17M(-9.2%) |
Mar 2015 | -$49.52M(-446.4%) | $65.58M(+117.2%) | -$67.37M(-65.3%) |
Dec 2014 | - | $30.19M(-128.2%) | -$194.10M(-10.2%) |
Sep 2014 | - | -$106.98M(+90.5%) | -$216.10M(+66.0%) |
Jun 2014 | - | -$56.16M(-8.2%) | -$130.19M(+3515.2%) |
Mar 2014 | $14.30M(-246.6%) | -$61.15M(-846.2%) | -$3.60M(-109.0%) |
Dec 2013 | - | $8.19M(-138.9%) | $39.90M(+5.6%) |
Sep 2013 | - | -$21.08M(-129.9%) | $37.80M(+113.9%) |
Jun 2013 | - | $70.43M(-499.1%) | $17.67M(-153.6%) |
Mar 2013 | -$9.75M(-109.6%) | -$17.65M(-389.7%) | -$32.97M(-73.0%) |
Dec 2012 | - | $6.09M(-114.8%) | -$121.99M(+263.6%) |
Sep 2012 | - | -$41.21M(-308.2%) | -$33.55M(-135.9%) |
Jun 2012 | - | $19.79M(-118.6%) | $93.43M(+19.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2012 | $101.19M(<-9900.0%) | -$106.67M(-212.8%) | $78.27M(-70.4%) |
Dec 2011 | - | $94.53M(+10.2%) | $264.19M(+75.8%) |
Sep 2011 | - | $85.78M(+1751.1%) | $150.28M(+1690.8%) |
Jun 2011 | - | $4.63M(-94.2%) | $8.39M(-201.3%) |
Mar 2011 | -$241.70K(-99.8%) | $79.25M(-508.9%) | -$8.28M(-57.5%) |
Dec 2010 | - | -$19.38M(-65.5%) | -$19.48M(-51.3%) |
Sep 2010 | - | -$56.11M(+366.1%) | -$40.03M(-6.9%) |
Jun 2010 | - | -$12.04M(-117.7%) | -$42.98M(-61.6%) |
Mar 2010 | -$105.82M(+209.8%) | $68.05M(-270.4%) | -$112.05M(-48.0%) |
Dec 2009 | - | -$39.93M(-32.4%) | -$215.54M(+21.3%) |
Sep 2009 | - | -$59.07M(-27.2%) | -$177.66M(+125.4%) |
Jun 2009 | - | -$81.10M(+128.9%) | -$78.82M(+43.1%) |
Mar 2009 | -$34.16M(-79.8%) | -$35.44M(+1618.6%) | -$55.06M(+600.4%) |
Dec 2008 | - | -$2.06M(-105.2%) | -$7.86M(-46.0%) |
Sep 2008 | - | $39.78M(-169.4%) | -$14.55M(-72.1%) |
Jun 2008 | - | -$57.34M(-587.5%) | -$52.10M(-73.5%) |
Mar 2008 | -$169.43M(-532.4%) | $11.76M(-234.3%) | -$196.26M(-29.4%) |
Dec 2007 | - | -$8.75M(-492.2%) | -$277.89M(+94.2%) |
Sep 2007 | - | $2.23M(-101.1%) | -$143.12M(-15.3%) |
Jun 2007 | - | -$201.50M(+188.4%) | -$168.90M(-532.9%) |
Mar 2007 | $39.18M(-93.7%) | -$69.86M(-155.4%) | $39.01M(-94.6%) |
Dec 2006 | - | $126.01M(-635.2%) | $716.91M(+23.2%) |
Sep 2006 | - | -$23.55M(-467.4%) | $582.04M(-2.8%) |
Jun 2006 | - | $6.41M(-98.9%) | $598.61M(-3.2%) |
Mar 2006 | $621.50M(+1553.9%) | $608.03M(-6969.3%) | $618.26M(+2138.1%) |
Dec 2005 | - | -$8.85M(+26.8%) | $27.62M(-46.7%) |
Sep 2005 | - | -$6.98M(-126.8%) | $51.79M(+75.0%) |
Jun 2005 | - | $26.07M(+49.9%) | $29.60M(-31.4%) |
Mar 2005 | $37.58M(-1559.1%) | $17.39M(+13.6%) | $43.13M(+47.9%) |
Dec 2004 | - | $15.31M(-152.5%) | $29.17M(+197.4%) |
Sep 2004 | - | -$29.18M(-173.7%) | $9.81M(-69.6%) |
Jun 2004 | - | $39.60M(+1056.0%) | $32.27M(-493.2%) |
Mar 2004 | -$2.58M(+10.3%) | $3.43M(-184.6%) | -$8.21M(-13.9%) |
Dec 2003 | - | -$4.05M(-39.7%) | -$9.53M(+44.6%) |
Sep 2003 | - | -$6.71M(+668.6%) | -$6.59M(+72.5%) |
Jun 2003 | - | -$873.20K(-141.5%) | -$3.82M(+21.3%) |
Mar 2003 | -$2.33M(-107.6%) | $2.10M(-289.5%) | -$3.15M(-53.7%) |
Dec 2002 | - | -$1.11M(-71.8%) | -$6.80M(-69.5%) |
Sep 2002 | - | -$3.94M(+1847.3%) | -$22.27M(+4.1%) |
Jun 2002 | - | -$202.40K(-86.9%) | -$21.39M(-171.9%) |
Mar 2002 | $30.87M(-517.1%) | -$1.55M(-90.7%) | $29.73M(-4.9%) |
Dec 2001 | - | -$16.58M(+441.9%) | $31.28M(-34.6%) |
Sep 2001 | - | -$3.06M(-106.0%) | $47.86M(-6.0%) |
Jun 2001 | - | $50.92M | $50.92M |
Mar 2001 | -$7.40M(-158.5%) | - | - |
Mar 2000 | $12.65M(+29.0%) | - | - |
Mar 1999 | $9.81M(-449.0%) | - | - |
Mar 1998 | -$2.81M(-136.2%) | - | - |
Mar 1997 | $7.77M(+11.5%) | - | - |
Mar 1996 | $6.97M | - | - |
FAQ
- What is Dr. Reddy's Laboratories Limited annual cash flow from financing activities?
- What is the all time high annual CFF for Dr. Reddy's Laboratories Limited?
- What is Dr. Reddy's Laboratories Limited annual CFF year-on-year change?
- What is Dr. Reddy's Laboratories Limited quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Dr. Reddy's Laboratories Limited?
- What is Dr. Reddy's Laboratories Limited quarterly CFF year-on-year change?
- What is Dr. Reddy's Laboratories Limited TTM cash flow from financing activities?
- What is the all time high TTM CFF for Dr. Reddy's Laboratories Limited?
- What is Dr. Reddy's Laboratories Limited TTM CFF year-on-year change?
What is Dr. Reddy's Laboratories Limited annual cash flow from financing activities?
The current annual CFF of RDY is $264.87M
What is the all time high annual CFF for Dr. Reddy's Laboratories Limited?
Dr. Reddy's Laboratories Limited all-time high annual cash flow from financing activities is $621.50M
What is Dr. Reddy's Laboratories Limited annual CFF year-on-year change?
Over the past year, RDY annual cash flow from financing activities has changed by +$282.95M (+1564.88%)
What is Dr. Reddy's Laboratories Limited quarterly cash flow from financing activities?
The current quarterly CFF of RDY is -$701.00K
What is the all time high quarterly CFF for Dr. Reddy's Laboratories Limited?
Dr. Reddy's Laboratories Limited all-time high quarterly cash flow from financing activities is $608.03M
What is Dr. Reddy's Laboratories Limited quarterly CFF year-on-year change?
Over the past year, RDY quarterly cash flow from financing activities has changed by -$123.99M (-100.57%)
What is Dr. Reddy's Laboratories Limited TTM cash flow from financing activities?
The current TTM CFF of RDY is $119.13M
What is the all time high TTM CFF for Dr. Reddy's Laboratories Limited?
Dr. Reddy's Laboratories Limited all-time high TTM cash flow from financing activities is $716.91M
What is Dr. Reddy's Laboratories Limited TTM CFF year-on-year change?
Over the past year, RDY TTM cash flow from financing activities has changed by +$2.82M (+2.43%)